Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 12/20 | 0.50 |
| ▸ | CALCR | P30988 | 12/20 | 0.50 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.46 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.46 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.46 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSK | P43235 | 2/20 | 0.44 |
| ▸ | CTSH | P09668 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30932611 | 0.92 | EPHA2 (0.59) | EPHA2CXCR4NMUR2NMUR1 | |
| SCHEMBL29474446 | 0.88 | EPHA2 (0.57) | EPHA2CXCR4NMUR2NMUR1 | |
| SCHEMBL31356488 | 0.87 | EPHA2 (0.58) | EPHA2NMUR2NMUR1 | |
| SCHEMBL29881028 | 0.87 | OPRM1 (0.47) | RAMP3CALCREPHA2CXCR4NMUR2 | |
| SCHEMBL30003633 | 0.86 | EPHA2 (0.59) | EPHA2CXCR4NMUR2NMUR1 | |
| SCHEMBL29579268 | 0.85 | CXCR4 (0.48) | RAMP3CALCRCXCR4 | |
| SCHEMBL30974448 | 0.85 | RAMP3 (0.57) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL31412169 | 0.85 | OPRM1 (0.46) | RAMP3CALCREPHA2NMUR2NMUR1 | |
| SCHEMBL29496455 | 0.85 | RAMP3 (0.46) | RAMP3CALCREPHA2CTSLCTSS | |
| SCHEMBL31034448 | 0.84 | NRP1 (0.46) | EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111961115-B | Umami peptide and preparation method and application thereof | 宁波大学 | 2022-03-11 | — | — | CN | disclosed |